Tomaz B. Manzoni

University of Pennsylvania — United States

Medicine · Health Sciences

11h-index2.3kcitations17works5.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(9), Animal Virus Infections Studies(5), COVID-19 Clinical Research Studies(4), Viral gastroenteritis research and epidemiology(4), RNA Interference and Gene Delivery(3)

Publications17 total

Homologous and Heterologous Vaccination Regimens with mRNA and rVSV Platforms Induce Potent Immune Responses Against SFTSV Glycoprotein
Viruses·2025· 4 citedOpen Access
Safety, Immunogenicity, and Efficacy of a Recombinant Vesicular Stomatitis Virus Vectored Vaccine Against Severe Fever with Thrombocytopenia Syndrome Virus and Heartland Bandavirus
Vaccines·2024· 7 citedOpen Access
SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared with SARS-CoV-2 mRNA vaccinations
Cell Reports·2022· 40 citedOpen Access
Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses
Immunity·2022· 66 citedOpen Access
Safety, Immunogenicity and Efficacy of a Recombinant Vesicular Stomatitis Virus Vectored Vaccine Against Severe Fever with Thrombocytopenia Syndrome Virus and Heartland Bandaviruses
2021· 2 citedOpen Access
Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses
Immunity·2021· 662 citedOpen Access
Novel lipid nanoparticle provides potent SARS-CoV-2 mRNA vaccine at low dose with low local reactogenicity, high thermostability and limited systemic biodistribution
2021· 11 citedOpen Access
Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection
Cell·2021· 405 citedOpen Access
Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Antibody Responses in Children With Multisystem Inflammatory Syndrome in Children (MIS-C) and Mild and Severe Coronavirus Disease 2019 (COVID-19)
Journal of the Pediatric Infectious Diseases Society·2020· 61 citedOpen Access
SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody Generation
Immunity·2020· 386 citedOpen Access
Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection
2020· 75 citedOpen Access
SARS-CoV-2 antibody responses in children with MIS-C and mild and severe COVID-19
2020· 37 citedOpen Access
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice
Immunity·2020· 376 citedOpen Access
Table of Contents
American Journal Of Pathology·2020Open Access
Distinct Chronic Post-Viral Lung Diseases upon Infection with Influenza or Parainfluenza Viruses Differentially Impact Superinfection Outcome
American Journal Of Pathology·2019· 41 citedOpen Access
Defective (Interfering) Viral Genomes Re-Explored: Impact on Antiviral Immunity and Virus Persistence
Future Virology·2018· 104 citedOpen Access
The effect of HIV-1 Vif polymorphisms on A3G anti-viral activity in an in vivo mouse model
Retrovirology·2016· 8 citedOpen Access

Frequent Co-authors

Paul Bates(12), Philip Hicks(11), Drew Weissman(6), Scott E. Hensley(6), Norbert Pardi(5), Elizabeth M. Anderson(5), Eileen C. Goodwin(5), Marcus J. Bolton(5), Sigrid Gouma(5), E. John Wherry(5), Katlyn Lederer(4), Hiromi Muramatsu(4), Ying K. Tam(4), Florian Krammer(4), Michela Locci(4), Claudia P. Arevalo(4), Madison E. Weirick(4), Amy E. Baxter(4), Laura A. Vella(4), Mohamad‐Gabriel Alameh(3)